3344 Relationship between pembrolizumab exposure and efficacy/safety in 1016 patients (pts) with advanced or metastatic melanoma. (September 2015) - Kang, S.P.; Chatterjee, M.; Ahamadi, M.; De Alwis, D.; De Greef, R.; Elassaiss-Schaap, J.; Freshwater, T.; Mayawala, K.; Stone, J.; Ebbinghaus, S.; Turner, D.; Kondic, A.